Health Catalyst, Inc.
HCAT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $262,490 | $310,541 | $441,005 |
| - Cash | $40,305 | $50,712 | $341,968 | $249,645 |
| + Debt | $166,637 | $172,789 | $402,365 | $402,265 |
| Enterprise Value | – | $384,567 | $370,938 | $593,625 |
| Revenue | $76,323 | $80,721 | $79,413 | $79,606 |
| % Growth | -5.4% | 1.6% | -0.2% | – |
| Gross Profit | $37,816 | $38,241 | $36,235 | $34,691 |
| % Margin | 49.5% | 47.4% | 45.6% | 43.6% |
| EBITDA | -$3,939 | -$22,426 | -$3,891 | -$2,485 |
| % Margin | -5.2% | -27.8% | -4.9% | -3.1% |
| Net Income | -$22,229 | -$40,978 | -$23,742 | -$20,673 |
| % Margin | -29.1% | -50.8% | -29.9% | -26% |
| EPS Diluted | -0.32 | -0.59 | -0.35 | -0.33 |
| % Growth | 45.8% | -68.6% | -6.1% | – |
| Operating Cash Flow | -$464 | -$8,997 | $280 | -$3,527 |
| Capital Expenditures | -$4,807 | $230 | -$670 | -$4,833 |
| Free Cash Flow | -$5,271 | -$8,767 | -$390 | -$8,360 |